Philip Ashman

Track

Insider profile

Currently holds a position at Alimera Sciences Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, European Managing Director Alimera Sciences Inc Jan. 1, 2013 -
Philip Ashman's trades of Alimera Sciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
53.01
Quantity 62,411 +42.5%
Value US$4,322,404
Transaction date
Planned sale
Price
223.90
Quantity 71,939 -46.4%
Value US$565,317
Transaction date
Planned sale
Price
218.49
Quantity 7,620 -43.0%
Value US$1,473,450
Transaction date
Planned sale
Price
1.23
Quantity 12,750 -33.3%
Value US$15,695
Transaction date
Planned sale
Price
1.24
Quantity 12,750 -25.0%
Value US$15,779
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-05 2020-11-04
B Purchase
62,411 +42.5%
53.01
US$4,322,404 		62,411 +42.5% 53.01 US$4,322,404
2018-01-19 2018-01-19
PlS Planned sale
71,939 -46.4%
223.90
US$565,317 		71,939 -46.4% 223.90 US$565,317
2018-01-19 2018-01-18
PlS Planned sale
7,620 -43.0%
218.49
US$1,473,450 		7,620 -43.0% 218.49 US$1,473,450
2018-01-18 2018-01-17
PlS Planned sale
12,750 -33.3%
1.23
US$15,695 		12,750 -33.3% 1.23 US$15,695
2018-01-18 2018-01-16
PlS Planned sale
12,750 -25.0%
1.24
US$15,779 		12,750 -25.0% 1.24 US$15,779